CXA Celoxica

RNS Number:3919F
Celoxica Holdings PLC
09 October 2007

9 October 2007

                             CELOXICA HOLDINGS PLC
                         ("CELOXICA" OR "THE COMPANY")

      Placing of New Ordinary Shares to raise approximately #0.66 million

Celoxica Holdings plc (AIM: CXA) - a provider of electronic system level (ESL)
design technology for the embedded systems and accelerated computing markets,
today announces that 14,000,000 new ordinary shares of 1p each in the capital 
of the Company (the "Placing Shares") have been placed by Arbuthnot Securities
Limited with institutional, trade and other investors at a price of 4.75p per
share to raise approximately #0.66 million before expenses (the "Placing"). The
Placing Shares will represent approximately 16.6 per cent. of the Company's
enlarged issued share capital.

The net proceeds of the Placing will be used for working capital purposes.

Application has been made to the London Stock Exchange for the Placing Shares 
to be admitted to trading on AIM. The Placing Shares will rank pari passu with 
the existing issued ordinary shares of 1p each in the capital of the Company
('Ordinary Shares').

The Placing is conditional, inter alia, on the admission of the Placing Shares
to AIM becoming effective ('Admission'), which is expected to occur on 10
October 2007, when dealings in the Placing Shares are expected to commence.

Following Admission, the Company's enlarged issued share capital will comprise
84,307,434 ordinary shares with voting rights. The Company does not hold any
shares in treasury. This figure of 84,307,434 ordinary shares may be used by
shareholders in the Company as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change in their interest in, the share capital of the Company under the FSA's
Disclosure and Transparency Rules.

Jack Fryer, Chairman commented,

"Since the appointment of our new CEO, Lee Staines, we have seen significant
levels of interest in our high performance computing solutions, in particular 
in the international banking and life sciences sectors where increased computing
speed can yield significant competitive advantage. They are genuine indicators
of the much broader appeal and adoption of our solution in these and other
industries. We believe that the potential demand for our technology and current
market interest warrants continued focused investment. The additional funds will
enable the Company to strengthen its balance sheet and enable it to take
advantage of the opportunities that exist in the Accelerated Computing market
where our solutions are now gaining market acceptance. We would like to thank
our existing and new shareholders for their support."

ENQUIRIES

Celoxica Holdings plc                Tel. +44 (0)1235 863 656
Lee Staines, CEO
Michelle Young, CFO

ICIS                                 Tel. +44 (0) 20 7651 8688
Tom Moriarty
Caroline Evans-Jones

Arbuthnot                            Tel. +44 (0) 20 7012 2000
Tom Griffiths
Alasdair Younie

END


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEILFVLITLAIID

Celoxica (LSE:CXA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Celoxica (LSE:CXA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024